Back to Journals » Drug Design, Development and Therapy » Volume 9

Original Research

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life

      
Total article views   HTML views PDF downloads Totals
13,939 Dovepress* 11,865+ 1,919 13,784
PubMed Central* 2,074 873 2,947
Totals 13,939 2,792 16,731
*Since 15 April 2015
+Since July 2016

View citations on PubMed Central and Google Scholar